| Dr Matthew Timothy Mcewan, DO | |
|
11306 Bridgeport Way Sw Ste D, Lakewood, WA 98499-3037 | |
| (253) 983-9390 | |
| Not Available |
| Full Name | Dr Matthew Timothy Mcewan |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 11 Years |
| Location | 11306 Bridgeport Way Sw Ste D, Lakewood, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699114025 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sound Pain Alliance | 0941565162 | 36 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has acquired Proxeon A/S, an innovative supplier of products for proteomics analysis headquartered in Odense, Denmark.
Women in their 40s considering their first screening mammogram want information on potential harm and benefits and want to participate in the decision-making process, according to a study in the June 27 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, and the Oxford Health NHS Foundation Trust today announced a joint study published in the Behavior Research and Therapy journal showing almost two-thirds of people seeking treatment for anxiety or depression and who had sleep difficulty saw their mental health improve substantially more by combining enrollment in Sleepio, Big Health's digital therapeutic for insomnia, with NHS Improving Access to Psychological Therapies programme care, when compared to IAPT care alone.
BBSRC-funded researchers at UCL along with collaborators at King's College London have identified a molecule that could be the key to understanding the cause of neurodegenerative diseases such as motor neurone disease (MND).
Johns Hopkins scientists have uncovered new details of how smelly things create signals in the nose that eventually go to the brain. The findings raise issues about how the process involved has been described for many years in biology textbooks.
› Verified 6 days ago
| Entity Name | Sound Pain Alliance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649776394 PECOS PAC ID: 0941565162 Enrollment ID: O20180517001248 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has acquired Proxeon A/S, an innovative supplier of products for proteomics analysis headquartered in Odense, Denmark.
Women in their 40s considering their first screening mammogram want information on potential harm and benefits and want to participate in the decision-making process, according to a study in the June 27 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, and the Oxford Health NHS Foundation Trust today announced a joint study published in the Behavior Research and Therapy journal showing almost two-thirds of people seeking treatment for anxiety or depression and who had sleep difficulty saw their mental health improve substantially more by combining enrollment in Sleepio, Big Health's digital therapeutic for insomnia, with NHS Improving Access to Psychological Therapies programme care, when compared to IAPT care alone.
BBSRC-funded researchers at UCL along with collaborators at King's College London have identified a molecule that could be the key to understanding the cause of neurodegenerative diseases such as motor neurone disease (MND).
Johns Hopkins scientists have uncovered new details of how smelly things create signals in the nose that eventually go to the brain. The findings raise issues about how the process involved has been described for many years in biology textbooks.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Timothy Mcewan, DO 11306 Bridgeport Way Sw Ste D, Lakewood, WA 98499-3037 Ph: () - | Dr Matthew Timothy Mcewan, DO 11306 Bridgeport Way Sw Ste D, Lakewood, WA 98499-3037 Ph: (253) 983-9390 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has acquired Proxeon A/S, an innovative supplier of products for proteomics analysis headquartered in Odense, Denmark.
Women in their 40s considering their first screening mammogram want information on potential harm and benefits and want to participate in the decision-making process, according to a study in the June 27 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, and the Oxford Health NHS Foundation Trust today announced a joint study published in the Behavior Research and Therapy journal showing almost two-thirds of people seeking treatment for anxiety or depression and who had sleep difficulty saw their mental health improve substantially more by combining enrollment in Sleepio, Big Health's digital therapeutic for insomnia, with NHS Improving Access to Psychological Therapies programme care, when compared to IAPT care alone.
BBSRC-funded researchers at UCL along with collaborators at King's College London have identified a molecule that could be the key to understanding the cause of neurodegenerative diseases such as motor neurone disease (MND).
Johns Hopkins scientists have uncovered new details of how smelly things create signals in the nose that eventually go to the brain. The findings raise issues about how the process involved has been described for many years in biology textbooks.
› Verified 6 days ago